Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-specific transcript, Y-linked 23B (TTTY23B) is a long non-coding RNA (lncRNA) gene located on the Y chromosome[8][9]. It is non-protein coding and is expressed specifically in the testis[6][8]. TTTY23B is considered a Y-linked pseudogene or non-coding transcript, rather than a protein-coding gene or classical molecular target. There is no evidence to suggest it acts as a receptor, enzyme, transporter, or similar therapeutic target class. No functional characterization, well-documented disease linkage, biomarker utility, or relevance to drug action is present in current resources[6][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-specific transcript, Y-linked 23B (TTTY23B).